Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Immunology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0903526PMID 20107188PMCID PMC4256430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses

  2010cited by this paper
• Resolvin E 1 and Protectin D 1 Activate Inflammation-Resolution Programs

  2009cited by this paper
• Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

  2009cited by this paper
• A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects

  2009cited by this paper
• 12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis

  2009cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

  2009influential reference
• Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

  2009cited by this paper
• Formyl Peptide Receptor-Like 2 Is Expressed and Functional in Plasmacytoid Dendritic Cells, Tissue-Specific Macrophage Subpopulations, and Eosinophils 1

  2009cited by this paper
• Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

  2008influential reference
• Opposing regulation of neutrophil apoptosis through the formyl peptide receptor‐like 1/lipoxin A4 receptor: implications for resolution of inflammation

  2008cited by this paper
• G Protein Activation by the Leukotriene B4 Receptor Dimer

  2008cited by this paper
• Activation of the annexin 1 counter‐regulatory circuit affords protection in the mouse brain microcirculation

  2007cited by this paper
• Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells

  2007cited by this paper
• Resolvin E1 and protectin D1 activate inflammation-resolution programmes

  2007cited by this paper
• The Required Role of Endogenously Produced Lipoxin A4 and Annexin-1 for the Production of IL-10 and Inflammatory Hyporesponsiveness in Mice1

  2007cited by this paper
• Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.

  2007cited by this paper
• Anti-inflammatory functions of glucocorticoid-induced genes.

  2007cited by this paper
• Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes.

  2007cited by this paper
• Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.

  2007cited by this paper
• Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.

  2007cited by this paper
• Resolution of in flammation: state of the art, definitions and terms

  2006cited by this paper
• Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents.

  2006influential reference
• Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis1

  2006cited by this paper
• Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.

  2006cited by this paper
• Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes.

  2006cited by this paper
• Serum amyloid A is an innate immune opsonin for Gram-negative bacteria.

  2006cited by this paper
• Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis

  2006cited by this paper
• Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

  2006cited by this paper
• Neutrophils and immunity: challenges and opportunities

  2006cited by this paper
• Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors*

  2006cited by this paper
• The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo

  2006cited by this paper
• Immune cell migration in inflammation: present and future therapeutic targets

  2005cited by this paper
• Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice

  2005cited by this paper
• Formyl‐peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct

  2005cited by this paper
• Annexin 1‐deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro

  2005cited by this paper
• Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins1

  2005cited by this paper
• Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein Kinases*

  2005cited by this paper
• Identification of functional domains in the formyl peptide receptor‐like 1 for agonist‐induced cell chemotaxis

  2005cited by this paper
• Resolution of inflammation: the beginning programs the end

  2005cited by this paper
• Molecular circuits of resolution: formation and actions of resolvins and protectins

  2005cited by this paper
• Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor1

  2004cited by this paper
• An Annexin 1 N-Terminal Peptide Activates Leukocytes by Triggering Different Members of the Formyl Peptide Receptor Family1

  2004cited by this paper
• Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.

  2003influential reference
• Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.

  2003cited by this paper
• Identification, Cloning, and Functional Characterization of a Murine Lipoxin A4 Receptor Homologue Gene1

  2002cited by this paper
• Points of control in inflammation

  2002cited by this paper
• Arthritis critically dependent on innate immune system players.

  2002cited by this paper
• Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

  2002cited by this paper
• Formyl-peptide receptors revisited.

  2002influential reference
• Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis

  2002cited by this paper
• The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R

  2002cited by this paper
• Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.

  2001cited by this paper
• Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics.

  2001cited by this paper
• Amyloid β42 Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1

  2001cited by this paper
• Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation

  2000cited by this paper
• Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils.

  2000cited by this paper
• A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells

  1999cited by this paper
• Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.

  1999cited by this paper
• Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.

  1999cited by this paper
• Impaired Antibacterial Host Defense in Mice Lacking the N-formylpeptide Receptor

  1999influential reference
• N-Formylpeptides Induce Two Distinct Concentration Optima for Mouse Neutrophil Chemotaxis by Differential Interaction with Two N-Formylpeptide Receptor (Fpr) Subtypes

  1999cited by this paper
• Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1.

  1998cited by this paper
• Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse.

  1998cited by this paper
• Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.

  1997influential reference
• Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

  1997cited by this paper
• Endogenous mediators that inhibit the leukocyte-endothelium interaction.

  1997cited by this paper
• Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration

  1996cited by this paper
• Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.

  1993cited by this paper
• Pathway to carrageenan-induced inflammation in the hind limb of the rat.

  1987cited by this paper
• Mouse paw edema. A new model for inflammation?

  1987cited by this paper
• The FASEB Journal express article 10.1096/fj.02-0239fje. Published online December 3, 2002. Aberrant inflammation and resistance to glucocorticoids in Annexin 1 –/ – Mouse

  year unknowncited by this paper

• Maresin 1 promotes resolution of inflammation and improves left ventricle function in acute heart failure.

  2026cites this paper
• G protein-coupled receptors and inflammation resolution signaling networks in the heart: Pharmacology and potential for innovative therapeutics

  2026cites this paper
• Annexin A1/FPR2 pathway modulates leukocyte function during Escherichia coli‐induced pneumonia to promote resolution of inflammation and restores lung function

  2025cites this paper
• Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential

  2025cites this paper
• Formyl peptide receptor 2 is a potential biomarker and therapeutic target for inflammatory bowel disease

  2025cites this paper
• Lipoxins as Modulators of Diseases

  2025cites this paper
• Formylpeptide receptors: A novel target to treat cardiometabolic complications.

  2025cites this paper
• Formylpeptide receptors in GtoPdb v.2025.3

  2025cites this paper
• Resolution Pharmacology: State-of-the-art and therapeutic landscape

  2025cites this paper
• Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers

  2025cites this paper
• SAA1 as a Potential Early Diagnostic Biomarker for Sepsis Through Integrated Proteomics and Metabolomics.

  2025cites this paper
• Leukotriene receptors in GtoPdb v.2025.3

  2025cites this paper
• Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis

  2025cites this paper
• Formylpeptide receptors in GtoPdb v.2025.1

  2025cites this paper
• Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responses

  2024cites this paper
• Treatment with lipoxin A4 improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responses.

  2024cites this paper
• Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation

  2024cites this paper
• Protective Effects of Lipoxin A4 and B4 Signaling on the Inner Retina in a Mouse Model of Experimental Glaucoma

  2024cites this paper
• Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review

  2024cites this paper
• The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies.

  2024cites this paper
• GRK5 regulates endocytosis of FPR2 independent of β-arrestins

  2024cites this paper
• The pro‐resolving mediator, annexin A1 regulates blood pressure, and age‐associated changes in cardiovascular function and remodeling

  2024cites this paper
• Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles

  2024cites this paper
• Promising Anti-Inflammatory Tools: Biomedical Efficacy of Lipoxins and Their Synthetic Pathways

  2023cites this paper
• Fpr2−/− Mice Developed Exacerbated Alcohol-Associated Liver Disease

  2023influential citation
• LXA4 inhibits TGF-β1-induced airway smooth muscle cells proliferation and migration by suppressing the Smad/YAP pathway.

  2023cites this paper
• Inhaled toxicants and pulmonary lipid metabolism: biological consequences and therapeutic interventions.

  2023cites this paper
• A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn’s Disease

  2023cites this paper
• Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands

  2023cites this paper
• Fpr2 exacerbates Streptococcus suis-induced streptococcal toxic shock-like syndrome via attenuation of neutrophil recruitment

  2023cites this paper
• Lipoxin Mimetics and the Resolution of Inflammation.

  2023cites this paper
• Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis

  2023influential citation
• LIPOXIN-MEDIATED SIGNALING: ALX/FPR2 INTERACTION AND BEYOND.

  2023cites this paper
• Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease

  2023cites this paper
• Leukotriene receptors in GtoPdb v.2023.1 Leukotriene receptors in GtoPdb v.2023.1

  2023cites this paper
• Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis

  2023cites this paper
• Immunomodulation of periodontitis with SPMs

  2023cites this paper
• Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies

  2023cites this paper
• Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity

  2023cites this paper
• Inhibitory role of Annexin A1 in pathological bone resorption and therapeutic implications in periprosthetic osteolysis

  2022cites this paper
• Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35

  2022cites this paper
• Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation

  2022cites this paper
• Resolution of Inflammation after Skeletal Muscle Ischemia–Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins

  2022cites this paper
• Resolution of inflammation: Intervention strategies and future applications.

  2022cites this paper
• Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

  2022cites this paper
• LipoxinA4 analog BML-111 protects podocytes cultured in high-glucose medium against oxidative injury via activating Nrf2 pathway.

  2022cites this paper
• Effects of Formyl Peptide Receptor Agonists Ac9-12 and WKYMV in In Vivo and In Vitro Acute Inflammatory Experimental Models

  2022cites this paper
• Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

  2022cites this paper
• Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis

  2022cites this paper
• Promiscuous Receptors and Neuroinflammation: The Formyl Peptide Class

  2022cites this paper
• Lipoxin A4 and its analog attenuate high fat diet-induced atherosclerosis via Keap1/Nrf2 pathway.

  2022cites this paper
• Annexins and cardiovascular diseases: Beyond membrane trafficking and repair

  2022cites this paper
• Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors

  2022cites this paper
• Efferocytosis and enhanced FPR2 expression following apoptotic cell instillation attenuate radiation-induced lung inflammation and fibrosis.

  2022cites this paper
• Annexin A1-FPR2/ALX Signaling Axis Regulates Acute Inflammation during Chikungunya Virus Infection

  2022cites this paper
• Mesenchymal Stem Cells and Formyl Peptide Receptor 2 Activity in Hyperoxia-Induced Lung Injury in Newborn Mice

  2022influential citation
• Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity

  2022cites this paper
• Protective effects of annexin A1-derived peptide Ac2-26 on liver and kidney injuries induced by cisplatin in rats.

  2022cites this paper
• Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population

  2022cites this paper
• Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms

  2022cites this paper
• Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases.

  2022cites this paper
• Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease

  2022cites this paper
• Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model

  2021cites this paper
• Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation

  2021cites this paper
• Cadmium Exposure Induces TNF-α-Mediated Necroptosis via FPR2/TGF-β/NF-κB Pathway in Swine Myocardium.

  2021cites this paper
• Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer

  2021cites this paper
• The resolvin D 1 receptor GPR 32 transduces inflammation-resolution and atheroprotection 1 2

  2021influential citation
• Electroacupuncture decreases inflammatory pain through a pro-resolving mechanism involving the peripheral annexin A1-formyl peptide receptor 2/ALX-opioid receptor pathway

  2021cites this paper
• Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages

  2021cites this paper
• Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation.

  2021cites this paper
• Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease

  2021cites this paper
• MAP kinases in regulation of NOX activity stimulated through two types of formyl peptide receptors in murine bone marrow granulocytes.

  2021cites this paper
• Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular Diseases

  2021cites this paper
• The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship?

  2021cites this paper
• The resolvin D1 receptor GPR32 transduces inflammation-resolution and atheroprotection.

  2021influential citation
• Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma

  2021cites this paper
• Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function

  2021cites this paper
• Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis

  2021cites this paper
• Chia oil prevents chemical and immune-mediated inflammatory responses in mice: Evidence for the underlying mechanisms.

  2021cites this paper
• Resolvin D1 Attenuates Innate Immune Reactions in Experimental Subarachnoid Hemorrhage Rat Model

  2021cites this paper
• Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis.

  2021cites this paper
• Atherosclerosis is a Major Human Killer and Non-resolving Inflammation is a Prime Suspect.

  2021cites this paper
• Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1

  2021cites this paper
• Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages

  2020cites this paper
• Patrolling Alveolar Macrophages Conceal Bacteria from the Immune System to Maintain Homeostasis.

  2020cites this paper
• The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice

  2020cites this paper
• Lipoxin A4 impairs effective bacterial control and potentiates joint inflammation and damage caused by Staphylococcus aureus infection

  2020cites this paper
• Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases

  2020cites this paper
• The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing

  2020cites this paper
• The turning away of serum amyloid A biological activities and receptor usage

  2020cites this paper
• G-protein coupled receptors involved in the resolution of inflammation: ligands and therapeutic perspectives.

  2020cites this paper
• The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis

  2020cites this paper
• Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• N-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells—An In Vitro Model for Early Inflammatory Profiling of Schwann Cells

  2020cites this paper
• The roles of small‐molecule inflammatory mediators in rheumatoid arthritis

  2020cites this paper
• Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

  2020cites this paper
• Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID‐19 therapy

  2020cites this paper
• Decreased Placental FPR2 in Early Pregnancies That Later Developed Small-For-Gestation Age: A Potential Role of FPR2 in the Regulation of Epithelial-Mesenchymal Transition

  2020cites this paper
• Activation of the pro-resolving receptors Fpr2/3 attenuate lipopolysaccharide-induced inflammatory microglial activation

  2020cites this paper
• Druggable Lipid Signaling Pathways

  2020cites this paper